» Articles » PMID: 28436273

Proteome Analysis of Sheep B Lymphocytes in the Course of Bovine Leukemia Virus-induced Leukemia

Overview
Specialty Biology
Date 2017 Apr 25
PMID 28436273
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Presented are the results of a study of the expression pattern of different proteins in the course of bovine leukemia virus-induced leukemia in experimental sheep and I discuss how the obtained data may be useful in gaining a better understanding of the pathogenesis of the disease, diagnosis, and for the selection of possible therapeutic targets. In cattle, the disease is characterized by life-long persistent lymphocytosis leading to leukemia/lymphoma in about 5% of infected animals. In sheep, as opposed to cattle, the course of the disease is always fatal and clinical symptoms usually occur within a three-year period after infection. For this reason, sheep are an excellent experimental model of retrovirus-induced leukemia. This model can be useful for human pathology, as bovine leukemia virus is closely related to human T-lymphotropic virus type 1. The data presented here provide novel insights into the molecular mechanisms of the bovine leukemia virus-induced tumorigenic process and indicate the potential marker proteins both for monitoring progression of the disease and as possible targets of pharmacological intervention. A study of the proteome of B lymphocytes from four leukemic sheep revealed 11 proteins with altered expression. Among them, cytoskeleton and intermediate filament proteins were the most abundant, although proteins belonging to the other functional groups, i.e. enzymes, regulatory proteins, and transcription factors, were also present. It was found that trypsin inhibitor, platelet factor 4, thrombospondin 1, vasodilator-stimulated phosphoprotein, fibrinogen alpha chain, zyxin, filamin-A, and vitamin D-binding protein were downregulated, whereas cleavage and polyadenylation specificity factor subunit 5, non-POU domain-containing octamer-binding protein and small glutamine-rich tetratricopeptide repeat-containing protein alpha were upregulated. Discussed are the possible mechanisms of their altered expression and its significance in the bovine leukemia virus-induced leukemogenic process. Impact statement The submitted manuscript provides new data on the molecular mechanisms of BLV-induced tumorigenic process indicating the potential marker proteins both for monitoring the progression of the disease and as possible targets of pharmacological intervention. This is to my knowledge the first study of the proteome of the transformed lymphocytes in the course of bovine leukemia virus-induced leukemia in susceptible animals. BLV can be considered as useful model for related human pathogen - HTLV-1, another member of the deltaretrovirus genus evolutionary closely related to BLV. Information gathered in this study can be useful to speculate on possible shared mechanisms of deltaretrovirus-induced carcinogenesis.

Citing Articles

HTLV-1 Infection and Pathogenesis: New Insights from Cellular and Animal Models.

Forlani G, Shallak M, Accolla R, Romanelli M Int J Mol Sci. 2021; 22(15).

PMID: 34360767 PMC: 8347336. DOI: 10.3390/ijms22158001.


Co-Circulation of Bovine Leukemia Virus Haplotypes among Humans, Animals, and Food Products: New Insights of Its Zoonotic Potential.

Corredor-Figueroa A, Olaya-Galan N, Velandia-Alvarez S, Munoz M, Salas-Cardenas S, Ibanez-Pinilla M Int J Environ Res Public Health. 2021; 18(9).

PMID: 34064361 PMC: 8124648. DOI: 10.3390/ijerph18094883.


Polyglutamine Repeats in Viruses.

Schein C Mol Neurobiol. 2018; 56(5):3664-3675.

PMID: 30182336 PMC: 6399083. DOI: 10.1007/s12035-018-1269-4.

References
1.
Rubashkin M, Cassereau L, Bainer R, DuFort C, Yui Y, Ou G . Force engages vinculin and promotes tumor progression by enhancing PI3K activation of phosphatidylinositol (3,4,5)-triphosphate. Cancer Res. 2014; 74(17):4597-611. PMC: 4191931. DOI: 10.1158/0008-5472.CAN-13-3698. View

2.
Kobayashi H, Gotoh J, Fujie M, Terao T . Characterization of the cellular binding site for the urinary trypsin inhibitor. J Biol Chem. 1994; 269(32):20642-7. View

3.
Bernusso V, Machado-Neto J, Pericole F, Vieira K, Duarte A, Traina F . Imatinib restores VASP activity and its interaction with Zyxin in BCR-ABL leukemic cells. Biochim Biophys Acta. 2014; 1853(2):388-95. DOI: 10.1016/j.bbamcr.2014.11.008. View

4.
Sun G, Wei C, Jing S, Hu W . Interactions between filamin A and MMP-9 regulate proliferation and invasion in renal cell carcinoma. Asian Pac J Cancer Prev. 2014; 15(8):3789-95. DOI: 10.7314/apjcp.2014.15.8.3789. View

5.
Truong Nguyen L, Chan S, Ngo T, Raval A, Kim K, Majeti R . Interaction of TIF-90 and filamin A in the regulation of rRNA synthesis in leukemic cells. Blood. 2014; 124(4):579-89. DOI: 10.1182/blood-2013-12-544726. View